DanielPeterSilverMD

PubMed

• PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
  Ranju Kunwor, Daniel P Silver, Maysa Abu-Khalaf> ;Hematology/oncology and Stem Cell Therapy. 2023 Apr 4
• 1 citations
  Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.
  Maysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, Rui Luo, Weelic Chong, Daniel P Silver, Frederick Fellin, Rebecca Jaslow, AnaMaria Lopez, Terrence Cescon, Wei Jiang, Rona...> ;Cancers. 2022 Jun 10
• 13 citations
  Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer
  Rui Luo, Weelic Chong, Qiang Wei, Zhenchao Zhang, Chun Wang, Zhong Ye, Maysa M. Abu-Khalaf, Daniel P. Silver, Robert Stapp, Wei Jiang, Ronald E. Myers, Bingshan Li, Ma...> ;NPJ Breast Cancer. 2021 Jun 1
• Duodenal and Biliary Obstruction due to Extrinsic CompressionDuodenal and Biliary Obstruction due to Extrinsic Compression by Recurrent Lobular Breast Carcinoma: A Cas...
  Rukaiya Bashir Hamidu, Bilal Asif, Harish Lavu, Thomas E. Kowalski, Daniel P. Silver> ;Case Reports in Gastroenterology. 2021 Jan 1
• 3 citations
  Neuroendocrine Tumors Are Enriched in Cowden Syndrome.
  Alison Greidinger, Susan Miller-Samuel, Veda N. Giri, Michele Sue-Ann Woo, Saranya Akumalla, Charnita Zeigler-Johnson, Scott W. Keith, Daniel P. Silver> ;JCO Precision Oncology. 2020 Jun 1
• 18 citations
  Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Poole...
  Melinda L. Telli, Charles Chu, Sunil Badve, Shaveta Vinayak, Daniel P. Silver, Steven J. Isakoff, Virginia G. Kaklamani, William J. Gradishar, Vered Stearns, Roisin M....> ;Clinical Cancer Research. 2020 Jun 1
• 22 citations
  Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
  Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M. Abu-Khalaf, Daniel P. Silver, Juan P. Palazzo, Geetha Jagannathan, Frederick M. Fellin, Saveri Bhattacharya, ...> ;Breast Cancer Research and Treatment. 2020 May 4
• 30 citations
  Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;European Journal of Cancer. 2019 Jan 1
• 38 citations
  Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple negative breast and serous ovarian cancers
  Nicolai Juul Birkbak, Yi Li, Shailja Pathania, April Greene-Colozzi, Matija Dreze, Christian Bowman-Colin, Zsofia Sztupinszki, Marcin Krzystanek, Miklos Diossy, Nadine...> ;Annals of Oncology. 2018 Apr 1
• 29 citations
  Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
  Jessalyn M. Ubellacker, Marie-Therese Haider, Molly J. DeCristo, Gloria Allocca, Nicola J. Brown, Daniel P. Silver, Ingunn Holen, Sandra S. McAllister> ;Breast Cancer Research. 2017 Mar 6
• 589 citations
  Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
  Melinda L. Telli, Kirsten Timms, Julia Reid, Bryan T. Hennessy, Gordon B. Mills, Kristin C. Jensen, Zoltan Szallasi, William T. Barry, Eric P. Winer, Nadine Tung, Stev...> ;Clinical Cancer Research. 2016 Aug 1
• 40 citations
  MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism that Mimics the Role of Activated RAS in Malignancy
  Manish Neupane, Allison P. Clark, Serena Landini, Nicolai Juul Birkbak, Aron Charles Eklund, Elgene Lim, Aedín C. Culhane, William T. Barry, Steven E. Schumacher, Rame...> ;Cancer Discovery. 2016 Jan 1
• 171 citations
  Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs
  Andrea Marion Marquard, Aron Charles Eklund, Tejal Joshi, Marcin Krzystanek, Francesco Favero, Zhigang C. Wang, Andrea L. Richardson, Daniel P. Silver, Zoltan Szallasi...> ;Biomarker Research. 2015 May 1
• 39 citations
  BRCA1 pathway function in basal-like breast cancer cells.
  Sarah J. Hill, Allison P. Clark, Daniel P. Silver, David M. Livingston> ;Molecular and Cellular Biology. 2014 Oct 15
• 96 citations
  Mechanisms of BRCA1 Tumor Suppression
  Daniel P. Silver, David M. Livingston> ;Cancer Discovery. 2012 Aug 1
• 1346 citations
  Mutational Processes Molding the Genomes of 21 Breast Cancers
  Serena Nik-Zainal, Ludmil B. Alexandrov, David C. Wedge, Peter Van Loo, Christopher Greenman, Keiran Raine, David T. Jones, Jonathan Hinton, John D Marshall, Lucy Steb...> ;Cell. 2012 May 25
• 385 citations
  Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
  Nicolai Juul Birkbak, Zhigang C. Wang, Ji Young Kim, Aron Charles Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J. Dirk Igleh...> ;Cancer Discovery. 2012 Apr 1
• 15 citations
  Chek2 DNA Damage Response Pathway and Inherited Breast Cancer Risk
  Nadine Tung, Daniel P. Silver> ;Journal of Clinical Oncology. 2011 Oct 1
• 31 citations
  Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1 -associated breast cancers
  Nadine Tung, Alexander Miron, Stuart J. Schnitt, Shiva Gautam, Katharina Fetten, Jennifer Kaplan, Yosuf Yassin, Ayodele Buraimoh, Ji Young Kim, Attila Marcell Szász, R...> ;Breast Cancer Research. 2010 Nov 16
• 4 citations
  Poly ADP-ribose polymerase inhibitors: science and current clinical development.
  Joyce F. Liu, Daniel P. Silver> ;Current Opinion in Oncology. 2010 Nov 1
• 113 citations
  Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer
  Carey K. Anders, Eric P. Winer, James M. Ford, Rebecca Dent, Daniel P. Silver, George W. Sledge, Lisa A. Carey> ;Clinical Cancer Research. 2010 Oct 1
• 710 citations
  Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
  Daniel P. Silver, Andrea L. Richardson, Aron Charles Eklund, Zhigang C. Wang, Zoltan Szallasi, Qiyuan Li, Nicolai Ytterdal Juul, Chee-Onn Leong, Diana Calogrias, Ayode...> ;Journal of Clinical Oncology. 2010 Mar 1
• 644 citations
  Complex landscapes of somatic rearrangement in human breast cancer genomes.
  Philip J. Stephens, David J. McBride, Meng-Lay Lin, Ignacio Varela, Erin Pleasance, Jared T. Simpson, Lucy Stebbings, Catherine Leroy, Sarah Edkins, Laura Mudie, Chris...> ;Nature. 2009 Dec 24
• 153 citations
  Synthetic Lethality ― A New Direction in Cancer-Drug Development
  J. Dirk Iglehart, Daniel P. Silver> ;The New England Journal of Medicine. 2009 Dec 16
• 2 citations
  Estrogen Receptor–Negative Breast Cancer: New Insights into Subclassification and Targeting
  Jean J. Zhao, Daniel P. Silver> ;Clinical Cancer Research. 2009 Oct 15
• Join now to see all